PregLem Company
PregLem is a Swiss biopharmaceutical company that focuses on developing and selling innovative drugs for women's reproductive medicine.
.jpg)
Founded Date:
2006
Last Funding Type:
Series B
Headquarters:
Geneva
Investors Number:
4
Employee Number:
11-50
Industry:
Reproductive Health & Contraception
Last Funding Date:
2007-12-04
Funding Status:
M&A
Total Funding:
$58,248,124